{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:27:49Z","timestamp":1780424869932,"version":"3.54.1"},"reference-count":101,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Bridging the Gaps (BTG) in Leukemia, Lymphoma and Multiple Myeloma Consensus Conference 2025 brought together a multidisciplinary group of oncology experts to address the complexities of lymphoma management, focusing on mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and diffuse large B\u2010cell lymphoma (DLBCL). This article presents consensus recommendations\u00a0developed through a modified Delphi process, which emphasize the need for tailored therapeutic strategies in light of recent advancements in treatment options. Key recommendations include the screening for high\u2010risk features in MCL, use of the BOVen regimen (zanubrutinib, obinutuzumab, and venetoclax) for\n                    <jats:italic>TP53<\/jats:italic>\n                    \u2010aberrant cases, and integration of chimeric antigen receptor T\u2010cell therapy for patients with mantle cell lymphoma that is refractory to covalent Bruton tyrosine kinase inhibitors. For CLL, recommendations include consideration of time\u2010limited therapies for younger patients and a \u201cwatch and wait\u201d strategy for asymptomatic patients despite the improved activity and safety of current treatment regimens. For DLBCL, this article highlights the challenges in treatment sequencing and the role of circulating tumor DNA and minimal residual disease testing in monitoring disease progression. Overall, the conference describes the importance of ongoing research to refine management strategies and improve patient outcomes in lymphoma care, addressing the gaps in clinical practice where high\u2010level evidence is lacking.\n                  <\/jats:p>","DOI":"10.1002\/cncr.70389","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T21:18:28Z","timestamp":1775769508000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025"],"prefix":"10.1002","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-0970","authenticated-orcid":false,"given":"Alexey V.","family":"Danilov","sequence":"first","affiliation":[{"name":"Department of Hematology and Stem Cell Transplantation City of Hope National Medical Center  Duarte California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Coombs","sequence":"additional","affiliation":[{"name":"Department of Medicine University of California Irvine School of Medicine  Irvine California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tycel","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Hematology &amp; Hematopoietic Cell Transplantation City of Hope Cancer Center  Duarte California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Allan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Weill Cornell Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-5535","authenticated-orcid":false,"given":"Jacqueline C.","family":"Barrientos","sequence":"additional","affiliation":[{"name":"Columbia University Division of Hematology\/Oncology Mount Sinai Medical Center  Miami Beach Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[{"name":"Division Abramson Cancer Center University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Choi","sequence":"additional","affiliation":[{"name":"Sanford Stem Cell Institute and Division of Hematology\/Oncology University of California San Diego  San Diego California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-6481","authenticated-orcid":false,"given":"Jonathon B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Emory University School of Medicine  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology Cleveland Clinic Taussig Cancer Institute  Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Karmali","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Feinberg School of Medicine Northwestern University  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish","family":"Patel","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Department of Medicine Rutgers Robert Wood Johnson Medical School Rutgers Cancer Institute  New Brunswick New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sauter","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplant and Cell Therapy Services Memorial Sloan Kettering Cancer Center  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma Division of Cancer Medicine The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-8341","authenticated-orcid":false,"given":"Yucai","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazyar","family":"Shadman","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center University of Washington Medicine  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011763"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102007\u201006\u2010095331"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.8387"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201005\u2010521898"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00690"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061207"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010191921"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02370"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02214"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010023\u201001977\u2010y"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8262787"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00562"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02470"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(24)00184\u20103"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010192939"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600\u20100609.2003.00093.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010200735"},{"key":"e_1_2_9_19_1","unstructured":"ClinicalTrials.gov.Rituximab with or without stem cell transplant in treating patients with minimal residual disease\u2010negative mantle cell lymphoma in first complete remission. Accessed August 23 2025.https:\/\/ClinicalTrials.gov\/study\/NCT03267433"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010212973"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021306"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010206931"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201004\u2010779736"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31328"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010189505"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201002\u2010628792"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010181440"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102019\u2010123812"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025563"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205229"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)33108\u20102"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014162"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(24)00682\u2010X"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010198018"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103026(21)00195\u20102"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010198021"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010199710"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/gm451"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010845"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)30262\u20102"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024631"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010022\u201000756\u20109"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300696"},{"key":"e_1_2_9_46_1","doi-asserted-by":"crossref","unstructured":"HillBT.An alternative to \u2018watch and wait\u2019 for newly diagnosed chronic lymphocytic leukemia or small lymphocytic leukemia?Accessed August 23 2025.https:\/\/ashpublications.org\/thehematologist\/article\/doi\/10.1182\/hem.V21.6.2024614\/518306\/An\u2010Alternative\u2010to\u2010Watch\u2010and\u2010Wait\u2010for\u2010Newly","DOI":"10.1182\/hem.V21.6.2024614"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v78.4.895.bloodjournal784895"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00975"},{"key":"e_1_2_9_49_1","article-title":"Testing early treatment for patients with high\u2010risk chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL)","author":"National Cancer Institute","year":"2025","journal-title":"EVOLVE CLL\/SLL Study"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400029"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023659"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014206"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.03.010"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27546"},{"key":"e_1_2_9_55_1","unstructured":"National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): chronic lymphocytic leukemia\/small lymphocytic lymphoma. Version 3.2025. Accessed September 14 2025.https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201009\u2010806398"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010023\u201037648\u2010w"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010174750"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7009"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7036"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2515458"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409804"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102025\u20102129"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102019\u201001\u2010896290"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(18)30414\u20105"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(24)00196\u20107"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010186775"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011327"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(24)00070\u20106"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27563"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO\u201025\u201000166"},{"key":"e_1_2_9_73_1","unstructured":"ClinicalTrials.gov.Cirmtuzumab consolidation for treatment of patients with detectable CLL on venetoclax (venetoclax).September 2 2025. Accessed August 23 2025.https:\/\/ClinicalTrials.gov\/study\/NCT04501939"},{"key":"e_1_2_9_74_1","unstructured":"ClinicalTrials.gov.Pirtobrutinib and venetoclax with MRD detection for previously untreated chronic lymphocytic leukemia.July 18 2025. Accessed August 23 2025.https:\/\/ClinicalTrials.gov\/study\/NCT05677919"},{"key":"e_1_2_9_75_1","unstructured":"ClinicalTrials.gov.Front\u2010line VenObi combination followed by Ven or VenZan combination in patients with residual disease: a MRD tailored treatment for young patients with high\u2010risk CLL (VIS). Accessed August 23 2025.https:\/\/ClinicalTrials.gov\/study\/NCT05478512"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO\u201025\u201000925"},{"key":"e_1_2_9_77_1","unstructured":"ClinicalTrials.gov.DA\u2010EPOCH\u2010R induction followed by nivolumab consolidation in newly diagnosed MYC BCL2 and\/or BCL6 rearranged HGBL (HO152). Accessed August 23 2025.https:\/\/ClinicalTrials.gov\/study\/NCT03620578?term=NCT03620578&rank=1"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010181707"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01994"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010022\u201001618\u2010w"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(15)70106\u20103"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643\u20103230.BCD\u201021\u20100029"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010194909"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301665"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO\u201025\u201000399"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281640"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015789"},{"issue":"11","key":"e_1_2_9_88_1","first-page":"698","article-title":"DA\u2010R\u2010EPOCH vs R\u2010CHOP in DLBCL: how do we choose?","volume":"19","author":"Major A","year":"2021","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1546855"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.003"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.002"},{"key":"e_1_2_9_92_1","unstructured":"National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): B\u2010cell lymphomas. Version 1.2025. Accessed August 23 2025.https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b\u2010cell.pdf"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12982"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00303"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008374"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6262"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015478"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018730"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010197938"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01366"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009389"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008240"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.70389","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:03:56Z","timestamp":1779527036000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,15]]}},"alternative-id":["10.1002\/cncr.70389"],"URL":"https:\/\/doi.org\/10.1002\/cncr.70389","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"2025-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70389"}}